Status: current, Primitive. Date: 31-Mar 2023. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4794851000168117 | A/Sydney/5/2021 (H1N1)pdm09-like virus adjuvanted (AU substance) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4794861000168115 | A/Sydney/5/2021 (H1N1)pdm09-like virus adjuvanted | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| A/Sydney/5/2021 (H1N1)pdm09-like virus adjuvanted | Is a | medicinal substance | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Fluad Quad 2023 injection, 0.5 mL syringe | has Australian BoSS | True | A/Sydney/5/2021 (H1N1)pdm09-like virus adjuvanted | Inferred relationship | Some | 434824600 |
| Fluad Quad 2023 injection, 0.5 mL syringe | has intended active ingredient | True | A/Sydney/5/2021 (H1N1)pdm09-like virus adjuvanted | Inferred relationship | Some | 434824600 |
| influenza quadrivalent adjuvanted geriatric vaccine 2023 injection, 0.5 mL syringe | has Australian BoSS | True | A/Sydney/5/2021 (H1N1)pdm09-like virus adjuvanted | Inferred relationship | Some | 1283647162 |
| influenza quadrivalent adjuvanted geriatric vaccine 2023 injection, 0.5 mL syringe | has intended active ingredient | True | A/Sydney/5/2021 (H1N1)pdm09-like virus adjuvanted | Inferred relationship | Some | 1283647162 |
| influenza quadrivalent adjuvanted vaccine 2023 | has intended active ingredient | True | A/Sydney/5/2021 (H1N1)pdm09-like virus adjuvanted | Inferred relationship | Some | 1996500290 |
This concept is not in any reference sets
FHIR